search
Back to results

IntegRAted Chronic Care Program at Specialized AF Clinic Versus Usual CarE in Patients With Atrial Fibrillation - RACE4 (RACE4)

Primary Purpose

Atrial Fibrillation

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Specialized outpatient AF Clinic
Usual Care
Sponsored by
Maastricht University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation focused on measuring Integrated chronic care program, specialized outpatient AF clinic, Atrial Fibrillation guideline

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients with newly diagnosed AF detected on electrocardiogram (ECG), holter recordings or event recorder with a duration > 30 seconds, 3 months before inclusion or
  2. Patients with a history of diagnosed AF, with no regular control at a cardiologist for AF in the last 2 years and referred by a (non-)cardiologic medical specialist for new diagnostics or therapeutic issue;
  3. Age ≥18 years.

Exclusion Criteria:

  1. No electrocardiographic objectified AF;
  2. Unstable heart failure defined as NYHA IV or heart failure necessitating hospital admission < 3 months before inclusion;
  3. Acute coronary syndrome (acute myocardial infarction or instable angina pectoris, with two of the following characteristics: chest pain and/ or ischemic electrocardiographic changes, and/ or cardiac enzyme rise) < 3 months before inclusion;
  4. Untreated hyperthyroidism or < 3 months euthyroidism before inclusion;
  5. Foreseen pacemaker, internal cardioverter defibrillator, and/ or cardiac resynchronization therapy;
  6. Cardiac surgery ≤ 3 months before inclusion;
  7. Planned cardiac surgery;
  8. Regular control and treatment, also for AF, at another specialized outpatient cardiac clinic;
  9. Patient is not able to fill in the questionnaires;
  10. Participation in other clinical study.

Sites / Locations

  • Martini Ziekenhuis
  • UMCG
  • Spaarne Gasthuis
  • Medisch Centrum Leeuwarden
  • MUMC+
  • Canisius Wilhelmina Ziekenhuis Nijmegen
  • Zaans Medisch Centrum
  • Isala

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Specialized AF-clinic

Usual Care

Arm Description

Management of AF patients in specialized outpatient AF Clinics according to the principles of an integrated chronic care program (ICCP) performed by a nurse practitioner/ physician assistant/ specialised cardiovascular nurse, cardiologist, supported by an ICT decision support tool based on professional guidelines (CardioConsult AF®). The use of a web-based patient centered management of patient's own medication (Medication manager TM) was optional. A standardized diagnostic, treatment and follow-up pathway was performed within the ICCP. In addition, the intervention is based on identifying risk factors and potential problems in patients, and addressing needs through dynamic use of personalized education and adjustment of treatment.

Usual care provided by cardiologists at the regular outpatient clinic.

Outcomes

Primary Outcome Measures

The primary endpoint is a composite of unplanned admission to the hospital for any cardiovascular reason and cardiovascular death.

Secondary Outcome Measures

All components of the primary endpoint
All-cause mortality
Total number of unplanned all-cause hospitalizations
Duration of unplanned all-cause hospitalizations
Total number of unplanned cardiovascular hospitalizations
Duration of unplanned cardiovascular hospitalizations
Total number of unplanned hospitalizations related to atrial fibrillation
Duration of unplanned hospitalizations related to atrial fibrillation
Recurrent unplanned cardiovascular hospitalizations
Costs and cost-effectiveness
Costs, Quality Adjusted Life Years (QALYs) and Cost-effectiveness (Incremental Cost-Effectiveness Ratio - ICER)
Implementation of care
The extent to which the comprehensive cardiovascular treatment is in accordance with the most recent ESC guidelines Management of Atrial Fibrillation, the HF guidelines of acute and chronic heart failure and the CVD prevention guidelines
Patient Quality of life
General health-related QoL is measured by using the SF-36
Patient Quality of life
Patient's perception of severity of arrhythmia-related symptoms is measured by using the AFSS
Anxiety and/ or depression
HADS-NL
Knowledge of AF
Netherlands Knowledge Scale on AF
Compliance to medication
MMAS
Compliance to medication
To measure the level of activation of a specific individual the PAM-13 Dutch is used

Full Information

First Posted
October 16, 2012
Last Updated
May 22, 2019
Sponsor
Maastricht University Medical Center
Collaborators
Stichting Achmea Gezondheidszor, DSW, CZ Fonds, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Daiichi Sankyo, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT01740037
Brief Title
IntegRAted Chronic Care Program at Specialized AF Clinic Versus Usual CarE in Patients With Atrial Fibrillation - RACE4
Acronym
RACE4
Official Title
IntegRAted Chronic Care Program at a Specialized Atrial Fibrillation (AF) Clinic Versus Usual CarE in Patients With Atrial Fibrillation, an Investigator-initiated, Prospective, Randomised, Open Label, Blinded Outcome Assessment (PROBE) Controlled Multi-center Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
December 2012 (Actual)
Primary Completion Date
September 30, 2018 (Actual)
Study Completion Date
September 30, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Maastricht University Medical Center
Collaborators
Stichting Achmea Gezondheidszor, DSW, CZ Fonds, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Daiichi Sankyo, Inc.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Rationale: The treatment of patients with atrial fibrillation is often inadequate due to poor guideline adherence. An integrated chronic care program (ICCP) at a specialized AF-clinic was found to be superior to usual care provided by a cardiologist in terms of cardiovascular hospitalizations and cardiovascular mortality. Hypothesis: treatment at a specialized AF clinic is superior to usual care in terms of cardiovascular mortality and cardiovascular hospitalizations, cost-effectiveness, quality of life and guideline adherence. Objectives: primary objective is to show that an ICCP reduces cardiovascular hospitalizations and mortality. Study design: randomized controlled trial with two study arms: usual care provided by cardiologists (control) versus integrated chronic care program at a specialized AF clinic (intervention) in 8 hospitals in the Netherlands. The RACE4 is an event driven study. A total number of 246 events is needed. In total 1716 patients with newly diagnosed AF will be included. Total duration of the study is 5 years and 10 months with a minimal follow up of 1 year. Data is collected at inclusion, after 3, 6, 12 months, every year thereafter and at the end of the study. Study population: Patients older than 18 year with newly diagnosed AF. Intervention: The intervention is delivered through the specialized outpatient AF clinic. The multidisciplinary team at the AF clinic consists of a nurse practitioner or physician assistant or specialised cardiovascular nurse, cardiologist, and is guided by guidelines-based decision support software program based on the applicable ESC guideline recommendations. The use of a web-based patient centered management of patient's own medication (Medication manager TM) was optional. A standardized diagnostic, treatment and follow-up pathway was performed within the ICCP.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation
Keywords
Integrated chronic care program, specialized outpatient AF clinic, Atrial Fibrillation guideline

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
1375 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Specialized AF-clinic
Arm Type
Experimental
Arm Description
Management of AF patients in specialized outpatient AF Clinics according to the principles of an integrated chronic care program (ICCP) performed by a nurse practitioner/ physician assistant/ specialised cardiovascular nurse, cardiologist, supported by an ICT decision support tool based on professional guidelines (CardioConsult AF®). The use of a web-based patient centered management of patient's own medication (Medication manager TM) was optional. A standardized diagnostic, treatment and follow-up pathway was performed within the ICCP. In addition, the intervention is based on identifying risk factors and potential problems in patients, and addressing needs through dynamic use of personalized education and adjustment of treatment.
Arm Title
Usual Care
Arm Type
Active Comparator
Arm Description
Usual care provided by cardiologists at the regular outpatient clinic.
Intervention Type
Other
Intervention Name(s)
Specialized outpatient AF Clinic
Intervention Type
Other
Intervention Name(s)
Usual Care
Primary Outcome Measure Information:
Title
The primary endpoint is a composite of unplanned admission to the hospital for any cardiovascular reason and cardiovascular death.
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Secondary Outcome Measure Information:
Title
All components of the primary endpoint
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Title
All-cause mortality
Time Frame
Minimum of 1 year and a maximum of 5 years and 10 months
Title
Total number of unplanned all-cause hospitalizations
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Title
Duration of unplanned all-cause hospitalizations
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Title
Total number of unplanned cardiovascular hospitalizations
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Title
Duration of unplanned cardiovascular hospitalizations
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Title
Total number of unplanned hospitalizations related to atrial fibrillation
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Title
Duration of unplanned hospitalizations related to atrial fibrillation
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Title
Recurrent unplanned cardiovascular hospitalizations
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Title
Costs and cost-effectiveness
Description
Costs, Quality Adjusted Life Years (QALYs) and Cost-effectiveness (Incremental Cost-Effectiveness Ratio - ICER)
Time Frame
baseline, 1 year, 2 years, 3 years
Title
Implementation of care
Description
The extent to which the comprehensive cardiovascular treatment is in accordance with the most recent ESC guidelines Management of Atrial Fibrillation, the HF guidelines of acute and chronic heart failure and the CVD prevention guidelines
Time Frame
Follow up with minimum of 1 year and a maximum of 5 years and 10 months
Title
Patient Quality of life
Description
General health-related QoL is measured by using the SF-36
Time Frame
Baseline, 1 year, 2 years, 3 years
Title
Patient Quality of life
Description
Patient's perception of severity of arrhythmia-related symptoms is measured by using the AFSS
Time Frame
Baseline, 1 year, 2 years, 3 years
Title
Anxiety and/ or depression
Description
HADS-NL
Time Frame
Baseline, 1 year, 2 years, 3 years
Title
Knowledge of AF
Description
Netherlands Knowledge Scale on AF
Time Frame
Baseline, 1 year, 2 years, 3 years
Title
Compliance to medication
Description
MMAS
Time Frame
Baseline, 1 year, 2 years, 3 years
Title
Compliance to medication
Description
To measure the level of activation of a specific individual the PAM-13 Dutch is used
Time Frame
Baseline, 1 year, 2 years, 3 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with newly diagnosed AF detected on electrocardiogram (ECG), holter recordings or event recorder with a duration > 30 seconds, 3 months before inclusion or Patients with a history of diagnosed AF, with no regular control at a cardiologist for AF in the last 2 years and referred by a (non-)cardiologic medical specialist for new diagnostics or therapeutic issue; Age ≥18 years. Exclusion Criteria: No electrocardiographic objectified AF; Unstable heart failure defined as NYHA IV or heart failure necessitating hospital admission < 3 months before inclusion; Acute coronary syndrome (acute myocardial infarction or instable angina pectoris, with two of the following characteristics: chest pain and/ or ischemic electrocardiographic changes, and/ or cardiac enzyme rise) < 3 months before inclusion; Untreated hyperthyroidism or < 3 months euthyroidism before inclusion; Foreseen pacemaker, internal cardioverter defibrillator, and/ or cardiac resynchronization therapy; Cardiac surgery ≤ 3 months before inclusion; Planned cardiac surgery; Regular control and treatment, also for AF, at another specialized outpatient cardiac clinic; Patient is not able to fill in the questionnaires; Participation in other clinical study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
H.J.G.M. Crijns, prof. dr.
Organizational Affiliation
Maastricht University Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
I.C. Van Gelder, prof. dr.
Organizational Affiliation
UMCG
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
R.G. Tieleman, dr.
Organizational Affiliation
Martini Ziekenhuis
Official's Role
Principal Investigator
Facility Information:
Facility Name
Martini Ziekenhuis
City
Groningen
Country
Netherlands
Facility Name
UMCG
City
Groningen
Country
Netherlands
Facility Name
Spaarne Gasthuis
City
Haarlem
Country
Netherlands
Facility Name
Medisch Centrum Leeuwarden
City
Leeuwarden
Country
Netherlands
Facility Name
MUMC+
City
Maastricht
Country
Netherlands
Facility Name
Canisius Wilhelmina Ziekenhuis Nijmegen
City
Nijmegen
Country
Netherlands
Facility Name
Zaans Medisch Centrum
City
Zaandam
Country
Netherlands
Facility Name
Isala
City
Zwolle
Country
Netherlands

12. IPD Sharing Statement

Citations:
PubMed Identifier
31544925
Citation
Wijtvliet EPJP, Tieleman RG, van Gelder IC, Pluymaekers NAHA, Rienstra M, Folkeringa RJ, Bronzwaer P, Elvan A, Elders J, Tukkie R, Luermans JGLM, Van Asselt ADIT, Van Kuijk SMJ, Tijssen JG, Crijns HJGM; RACE 4 Investigators. Nurse-led vs. usual-care for atrial fibrillation. Eur Heart J. 2020 Feb 1;41(5):634-641. doi: 10.1093/eurheartj/ehz666.
Results Reference
derived

Learn more about this trial

IntegRAted Chronic Care Program at Specialized AF Clinic Versus Usual CarE in Patients With Atrial Fibrillation - RACE4

We'll reach out to this number within 24 hrs